MENU

Fox Chase Cancer Center News

July 17, 2020

Fox Chase Cancer Center and Ben-Gurion University Researchers Receive Grant to Continue Study of Cancer Treatment

PHILADELPHIA (July 17, 2020) – Scientists at Fox Chase Cancer Center and Ben-Gurion University of the Negev (BGU) have received a new grant from the United States-Israel Binational Science Foundation (BSF) that will fund continuing research on an antibody developed as part of a longstanding collaboration between the two organizations.

July 16, 2020

Fox Chase Researchers Create New Machine Learning Tool That Reduces False Positives in Virtual Screening

PHILADELPHIA (July 16, 2020)—Fox Chase Cancer Center researchers have concluded that heat and moisture exchanger (HME) cassettes are more effective at preventing mucus plugs following removal of the larynx than external tracheal humidification.

July 16, 2020

Research Finds Heat and Moisture Exchanger Cassettes More Effective for Mucus Plugs After Larynx Removal in Cancer Patients

PHILADELPHIA (July 16, 2020)—Fox Chase Cancer Center researchers have concluded that heat and moisture exchanger (HME) cassettes are more effective at preventing mucus plugs following removal of the larynx than external tracheal humidification.

July 15, 2020

Fox Chase Cancer Center Welcomes Brandon Bachert

PHILADELPHIA (July 15, 2020) – Fox Chase Cancer Center announces the hiring of Brandon Bachert, MD, who will join the department of diagnostic imaging as a full time body imager. Bachert will be an assistant professor on the academic track.

July 14, 2020

Fox Chase Cancer Center Welcomes J. Nicholas Bodor

PHILADELPHIA (July 14, 2020) – J. Nicholas Bodor, MD, PhD, MPH, will join the Department of Hematology/Oncology and serve in the Thoracic Oncology Program upon completion of the Fox Chase-Temple Hematology/Oncology Fellowship Program.

July 13, 2020

Genome Profiling, Fox Chase Cancer Center to Collaborate on Immune System Blood Test to Predict Checkpoint Inhibitor Response in Non-Small Cell Lung Cancer

PHILADELPHIA (July 13, 2020) – Genome Profiling and Fox Chase Cancer Center will collaborate to identify a novel immune system epigenetic biomarker, dubbed EpiMarker, which if successful, will be used to help predict which lung cancer patients are likely to respond to a checkpoint inhibitor therapy known as anti-PD1 antibody. These agents are a potentially valuable tool for lung cancer treatment, but it remains very difficult for doctors to predict which patients are most likely to benefit from them.

“We’re dealing with lung cancer and our lung cancer patients may be more at risk for severe disease due to COVID-19. A lot of the management we do puts them at greater risk after that,” said Sameera Kumar, MD, one of the authors on the paper and an assistant professor in the Department of Radiation Oncology.
July 1, 2020

Fox Chase Researchers Help Identify Best Practices for Cancer Patient Care During COVID-19

PHILADELPHIA (July 1, 2020)—Researchers at Fox Chase Cancer Center were part of a national team that published a paper identifying best practices for facilities to protect vulnerable cancer patients during the COVID-19 pandemic.

Dr. J.K. Wong
July 1, 2020

Fox Chase Researchers Look at Toxicity, Outcomes in Determining Treatments for Older Patients With Rectal Cancer

PHILADELPHIA (July 1, 2020)—In a recent study, researchers at Fox Chase Cancer Center found that factors other than just age can be useful in determining courses of treatment for older patients with locally advanced rectal cancer.

Pages

Connect with Fox Chase